Treatment of limb-threatening ischemia with percutaneous intentional extraluminal recanalization: a preliminary evaluation  by Treiman, Gerald S et al.
Treatment of limb-threatening ischemia with
percutaneous intentional extraluminal
recanalization: A preliminary evaluation
Gerald S. Treiman, MD, John H. Whiting, MD, Richard L. Treiman, MD,
Rose Marie McNamara, APRN-C, and Amir Ashrafi, Salt Lake City, Utah
Objective: We assessed the technical success, safety, and short-term effectiveness of percutaneous intentional extraluminal
recanalization (PIER) in patients with limb-threatening ischemia and no autologous vein or with a major contraindica-
tion to surgery.
Methods: From 1999 through 2002, 25 patients with femoropopliteal occlusion and rest pain or tissue loss underwent
PIER. Thirteen patients had undergone one or more failed bypass surgeries in the treated lower extremity, and no patient
had suitable vein for bypass grafting. In four patients the ejection fraction was less than 15%; four patients had severe
nonreconstructable coronary artery disease; and two patients with metastatic cancer refused amputation. All patients
underwent subintimal wire placement, followed by percutaneous transluminal angioplasty and intracoil stent placement.
Occlusions ranged in length from 6 to 18 cm, and 1 to 10 stents were placed. Technical success required no residual
stenosis greater than 30% on arteriography, velocity ratio less than 1.5 on duplex ultrasound scanning, and improvement
in ankle-brachial index of 0.15 or greater. Follow-up duplex scanning was performed every 3 months.
Results: Initial success was obtained in 23 of 25 patients (92%), with ankle-brachial index improvement of .31 to .54. All
successful procedures resulted in symptomatic improvement. Mean follow-up was 13.3 months (range, 4-30 months).
During follow-up, 10 patients died and 2 arteries demonstrated recurrent occlusion. With life table analysis, success rate
was 92% at 12 months. Of the 4 patients in whom the procedure failed, 3 required major amputation and symptoms
persisted in one. Complications occurred after two procedures, one myocardial infarction and one groin hematoma.
Conclusions: PIER is technically possible in patients with femoropopliteal occlusion, and the procedure is associated with
a low complication rate. Most procedures provide at least short-term clinical success and have enabled successful wound
healing and pain relief in patients without other effective options. Further studies and longer follow-up are required to
determine long-term success and the role of PIER in treatment of femoropopliteal occlusion. (J Vasc Surg 2003;38:
29-35.)
Despite advances in vascular surgery, an alternative to
autologous vein for infrainguinal arterial reconstruction has
not proved effective. For patients with either insufficient
venous conduit or contraindications to major arterial by-
pass surgery, prosthetic or cryopreserved grafts, laser or
balloon angioplasty, extended femoropopliteal or tibial
endarterectomy, and various other arterial options have
provided poor intermediate or even short-term patency.
In an attempt to improve the outcome in patients
requiring infrageniculate arterial reconstruction because of
limb-threatening ischemia but with no suitable vein, we
have used percutaneous intentional extraluminal recanali-
zation (PIER). On the basis of encouraging results from
European centers,1-11 we initially used the technique selec-
tively in patients for whom even the aforementioned op-
tions were either not possible or contraindicated. After our
initial successes, we cautiously used this approach in addi-
tional patients when vein bypass grafting was not possible.
We recognize that this procedure, like many others
before it, may prove to provide poor intermediate or long-
term patency and ultimately may not be a more effective
treatment in this group of patients. However, it was our
hope that if initial results were encouraging, others would
test the merits of this procedure, and we would continue to
use it selectively to obtain sufficient follow-up data to better
enable us to determine its effectiveness. The purpose of this
study was therefore to determine the safety and technical
feasibility of PIER in patients with femoropopliteal arterial
occlusion, to evaluate short-term and intermediate-term
patency and limb salvage, and to better define indications
for use of this approach.
METHODS AND MATERIALS
Patients. From 1999 through 2002, 136 patients
with femoropopliteal occlusive disease underwent interven-
tional treatment at the Veterans Administration Salt Lake
City Health Care System because of limb-threatening isch-
emia. Of these patients, 70 underwent arterial bypass graft-
ing with autogenous vein, 41 underwent percutaneous
transluminal angioplasty (PTA), and 25 underwent PIER.
Data for these 25 patients form the basis of this report.
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Clinical examination was performed to identify patients
with infrainguinal disease and limb-threatening ischemia,
and ankle-brachial index (ABI) and segmental arterial pres-
sure were obtained to document the severity of ischemia
and provide baseline hemodynamic data for follow-up.
Patients underwent duplex ultrasound (US) scanning to
determine whether a suitable autologous vein was available.
In addition, all patients underwent cardiac evaluation ac-
cording to criteria established by the American Heart As-
sociation to enable assessment of operative risk. Diagnostic
arteriography was performed by an interventional radiolo-
gist, and the results were reviewed by the vascular surgeon
and the radiologist to determine whether the pattern of
disease was suitable for either operative or endovascular
therapy. Patients with iliac artery stenosis or focal superficial
femoral artery (SFA) or popliteal artery stenosis usually
underwent PTA at the same time as diagnostic arteriogra-
phy. Femoropopliteal recanalization (PIER) was not usu-
ally attempted at the same time as iliac PTA, to minimize
contrast medium infusion and to allow time to assess clin-
ical improvement from treatment of the iliac lesion. Five
patients had previously undergone iliac PTA on the affected
side, and one had undergone aortobifemoral bypass graft-
ing. At the PIER procedure, no patient had iliac stenosis
greater than 30% or a pressure gradient at rest across the
iliac system. None of the 25 patients in this series had
residual hemodynamically significant aortoiliac disease.
Of the 25 study patients, 14 patients had complete SFA
and popliteal artery occlusion, with tibioperoneal trunk or
tibial artery reconstitution; 6 patients had SFA occlusion
with a patent distal popliteal artery; 4 patients had a patent
proximal SFA with distal SFA popliteal occlusion; and 1
patient had a patent femoropopliteal segment but proximal
occlusion of all three tibial arteries. Overall, three tibial
arteries were patent in 3 patients; 2 arteries were patent in
14 patients; 1 artery was patent in 7 patients; and no crural
artery was patent in 1 patient, although supramalleolar
reconstitution was present. The combination of femoro-
popliteal occlusion, tibial artery disease, and, in many cases,
pedal or microvascular atherosclerosis, explains the severity
of ischemia in these patients, as mainifested by clinical
symptoms and ABI.
Arterial bypass surgery would have necessitated pros-
thetic or cryopreserved vein grafted to a tibial artery. In our
experience, despite use of vein cuffs or patches, patency and
limb salvage with these grafts has been poor, and they were
not considered a desirable option. In addition to lack of
suitable conduit, in 4 patients ejection fraction was less than
15%; in 4 other patients coronary arteriograms demon-
strated severe, nonreconstructible coronary artery disease;
and 2 patients had metastatic cancer but refused amputa-
tion. Given the limited effective options for treatment in
these patients, we tried PIER on the basis of selected
reports of clinical success. After our initial success, we
continued to use this approach, and it gradually became our
preferred method of management for this group of pa-
tients.
Technique. The goal with PIER was to deliberately
enter the subintimal space with a guidewire proximal to an
arterial occlusion, traverse the occlusion, and reenter the
true lumen where the artery regained patency. The subin-
timal space was dilated with an angioplasty balloon to
create a suitable channel, and a stent was usually placed to
maintain patency and minimize risk for stenosis in the
recanalized segment.
Either ipsilateral or contralateral femoral puncture was
used, depending on the distance to the target lesion and
whether additional diagnostic arteriography was performed
concomitantly. For ipsilateral procedures, after common
femoral artery puncture and placement of a 7F or 8F
sheath, a 5F straight catheter was inserted through the
sheath and advanced to just above the lesion; then arteriog-
raphy was performed to confirm location of the catheter
and status of runoff vessels.
To obtain subintimal access, the straight catheter was
replaced with an angled catheter (Kumpe or Davis vertebral
catheter) and a straight 0.35 or 0.38 Terumo glide wire was
passed distally. Once beyond the lesion, the glide wire was
manipulated to enter the true lumen. Occasionally an Am-
platz extra-stiff 0.35 straight guidewire or the stiff back end
of a glide wire was used to initiate the dissection. Progress
was monitored constantly with arteriography with hand
injection of contrast medium.
After access across the lesion was achieved and the true
lumen was recanalized, the catheter and an extra-stiff wire
were advanced into the true lumen distal to the lesion in
preparation for PTA of the recanalized segment. PTA was
performed distal to proximal and was followed by place-
ment of intracoil stents sized to the diameter of the balloon
used. The entire length of the dissection was stented.
Repeat PTA of the stents was performed to secure their
location, and a completion angiogram was obtained.
Patients were given aspirin before diagnostic arteriog-
raphy and subsequent PIER, and aspirin therapy was con-
tinued after the procedure. Eleven patients were receiving
long-term warfarin sodium therapy, which was continued
during follow-up. Eight patients underwent thrombolysis
of the SFA or popliteal artery before PIER, and no patient
underwent surgery during the same hospitalization. Pa-
tients often received premedication with sublingual nifedi-
pine and intraarterial nitroglycerin (100-200 g bolus), at
the discretion of the treating physician, to minimize vaso-
spasm. After arterial puncture and cannulation, patients
received a 70 U/kg bolus of heparin, followed by 1000
U/hr of systemic heparin, and heparinization was not
reversed with protamine after completion of the procedure.
Patients received integrelin infusion for 24 hours in the
intensive care unit (ICU) after PIER. Before transfer to the
ICU, all patients underwent completion arteriography and
duplex US scanning.
Data analysis. Technical success required no stenosis
greater than 30% at completion arteriography; no velocity
ratio greater than 1.5 at duplex US scanning, comparing
the treated artery with the proximal patent vessel; and
JOURNAL OF VASCULAR SURGERY
July 200330 Treiman et al
improvement in ABI of .15 or greater or improvement in
tibial waveforms in patients with calcified or noncompress-
ible vessels.
During follow up, patients underwent clinical examina-
tion, including serial ABI determinations and duplex US
scanning, every 3 months for the first 2 years and at least
semiannually thereafter. Patients with recurrent symptoms,
unsatisfactory wound healing, or hemodynamic deteriora-
tion underwent duplex US scanning or arteriography
sooner. Failure was defined as stenosis greater than 50% or
recurrent occlusion of the treated arterial segment. The
Kaplan-Meier product limit method was used to create life
table plots, with failure equal to time from procedure to
recurrence of disease.
Results were analyzed and reported in accordance with
the reporting standards for lower extremity arterial endo-
vascular procedures.12 Treatment outcome was based on
intent to treat. To enable statistical analysis, unsuccessful
PIER procedures were recorded as failure at time t  0.
RESULTS
The 25 male patients ranged in age from 48 to 83 years
(mean, 71 years; Table I). Twenty-one patients had coro-
nary artery disease, including 16 patients who had under-
gone previous coronary artery bypass grafting; 18 patients
had hypertension; 14 patients were current or previous
cigarette users; 13 patients had diabetes mellitus; and 4
patients had hyperlipidemia, defined as requiring medica-
tion to treat elevated cholesterol or triglyceride concentra-
tion. Seven patients had undergone treatment for aortoiliac
disease, including ipsilateral iliac PTA in 5 patients, con-
tralateral iliac PTA in 1 patient, and aortobifemoral bypass
grafting in 1 patient. Previous treatment of the contralateral
extremity included femorotibial or femoropopliteal bypass
grafting in 12 patients, femorofemoral bypass grafting in 1
patient, and below-knee amputation in 2 patients. Thirteen
patients had undergone failed femoropopliteal or femoro-
crural bypass grafting in the affected extremity.
The indication for PIER was rest pain in 14 patients
(56%) and a nonhealing wound or gangrene in 11 patients
(44%). Mean preprocedure ABI in all patients was 0.29, but
was 0.38 in patients in whom treatment was successful
versus 0.11 in patients in whom treatment failed. The
popliteal artery was occluded in 19 patients and was patent
distally in 6 patients. Treatment involved the left lower
extremity in 14 patients and the right lower extremity in 11
patients. Occlusions ranged in length from 6 to 18 cm.
PIER was technically successful in 23 of the 25 patients,
as determined by the criteria defined (Figs 1, 2). All 23
patients had hemodynamic success, with improvement in
mean ABI of .23. No successfully treated patient required
major amputation or had persistent rest pain. Clinical suc-
cess and patency were therefore similar in this study. Re-
canalization could not be performed in 2 patients because
of inability to maintain patency of the recanalized artery
with angioplasty and stenting. Of the 2 patients in whom
the technique failed, 1 patient underwent above-knee am-
putation and 1 patient died without further therapy.
Morbidity included contralateral groin hematoma re-
quiring operative evacuation in 1 patient, and fatal myocar-
dial infarction 2 days after the procedure in a patient with
severe coronary artery disease who was not a candidate for
either coronary or infrainguinal bypass surgery.
All patients were in the ICU for 24 hours after the
procedure, and duration of hospitalization ranged from 1
to 9 days. Duration of the procedure ranged from 2 to 6
hours. Patients received 17 to 305 mL of contrast material,
depending on the need to image inflow or contralateral
vessels, whether further diagnostic information was re-
quired, whether digital subtraction arteriography or carbon
dioxide was used, and number of stents placed. From one
to 10 stents were placed.
Follow-up ranged from 4 to 36 months (mean, 13.3
months). Fifteen patients (60%) remained alive and 10
patients (40%) died, including the 1 patient with peripro-
cedural death. Six patients died from myocardial infarction,
3 patients died from metastatic cancer, and 1 patient died
from renal failure. In 2 of the 23 patients in whom treat-
ment was initially successful, arterial occlusion recurred,
and both patients required major amputation. Thrombo-
lytic therapy with repeat PTA and stent placement was
attempted in 1 of the 2 patients, but artery occlusion
recurred. No patient underwent a subsequent successful
endovascular procedure in the affected extremity. With life
table analysis, success was 92% at 12 months (Table II; Fig
3). Patency was 81% at 24 months, but this datum is
unreliable given the large standard of error at this time
interval.
Drawing meaningful conclusions from demographic
variables, cardiovascular risk factors, and other independent
variables is difficult because in the entire series treatment
failed in only 4 patients, at the initial procedure in 2
patients. These small numbers do not allow meaningful
analysis without a high likelihood of type II statistical error.
Nevertheless, we found that lesion length and presence of
Table I. Demographic information, cardiovascular risk
factors, and lesion characteristics in 25 patients
Variable Number Percent
Thrombolysis 8 32
Patent tibial arteries
0-1 8 32
2 14 56
3 3 12
Artery treated
SFA 6 24
SFA and popliteal 19 76
Occlusion length (cm)
9 16 64
10 9 36
Comorbidity
Diabetes mellitus 13 52
Hypertension 18 72
Coronary artery disease 21 84
Cigarette use 14 56
SFA, Superficial femoral artery.
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previously failed bypass surgery did not influence the like-
lihood of success with PIER.
DISCUSSION
PIER was first clinically used in 1987, and was first
reported by Bolia et al8 in 1990. The first reported cases of
recanalization of an occluded infrainguinal artery with cre-
ation of a dissection through the vessel wall were not
intentional but inadvertent. Similar to spontaneously oc-
curring dissections, in which the false channel may remain
patent for an extended period, it was observed that the
recanalized segment in these initial cases remained patent.
Consequently, a few centers elected to use this concept by
intentionally creating the dissection and providing distal
reentry into the patent runoff artery. It was hoped the
technique could more effectively treat long segment occlu-
sions, which have traditionally responded poorly to balloon
angioplasty, laser-assisted angioplasty, and endarterec-
tomy.
Similar to spontaneous arterial dissections, the newly
created plane was not always between the intima and the
media, but, as noted at pathologic examination in patients
who had subsequently died, was within the media or be-
tween the media and adventitia. Consequently, although
such dissection is frequently subintimal, it has been classi-
fied as extraluminal rather than subintimal, although there
has not yet been enough clinical experience to determine
the significance of the level of dissection within the wall.
There are several theoretical advantages to PIER com-
pared with traditional balloon angioplasty or endarterec-
tomy. Since the wire moves freely in the newly created
plane, the procedure enables treatment of long segments of
disease with minimal additional morbidity, similar to arte-
rial bypass grafting. The recanalized segment is not athero-
sclerotic and, because there is no true intima or endothe-
lium, may be at less risk for development of subsequent
atherosclerotic disease.
There is minimal risk of embolization, because plaque is
not ruptured. As opposed to spontaneous dissection, in
which there is concern about branch vessel occlusion, the
branch vessels are already occluded. Finally, failure to create
a reentry site or to secure successful wire passage is unlikely
to further jeopardize distal perfusion, because the proce-
dure is limited to a chronically occluded segment.
None of the patients in our study were candidates for
autologous vein bypass grafting, and some were not candi-
dates for other less effective procedures. In 13 patients one
or more bypass procedures in the affected artery had already
failed, and 10 patients were at prohibitive risk for any form
of operative revascularization. Therefore these patients af-
forded us the opportunity to use the PIER technique
without jeopardizing other approaches that theoretically
could be successful.
Our technical success rate of 92% is higher than that
reported from European centers.6,7,10,11 Reekers et al,1
reporting on 40 patients from The Netherlands, noted an
85% technical success rate, close to the 84% technical
success rate reported by Nydahl et al4 and the 80% technical
Fig 1. A, Arteriogram shows distal superficial femoral artery oc-
clusion before percutaneous intentional extraluminal recanaliza-
tion. B, Completion arteriogram obtained after the procedure and
stent placement.
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success rate noted by Bolia et al.8,9 Vraux et al,7 reviewing
experience in 36 patients from Belgium, reported a 74%
technical success rate. Most technical failures in other re-
ports resulted from failure to pass the wire into the extralu-
minal plane. Both technical failures in our series resulted
from inability to maintain patency of the recanalized lumen
despite successful wire and catheter passage.
As with other new procedures, it is hoped that with
increasing experience we will be able to better identify
patients likely to benefit from PIER, and become more
facile at wire and catheter manipulation and thereby reduce
the incidence of technical failure. In our experience and the
reports of others, technical failure has not caused clinical or
hemodynamic deterioration and has not resulted in occlu-
Fig 2. A, Arteriogram shows arterial occlusion before percutaneous intentional extraluminal recanalization. B,
Arteriogram obtained after successful wire passage through the lesion. C, Arteriogram obtained after placement of a
stent across the occluded segment. D, Completion arteriogram obtained after successful recanalization, percutaneous
transluminal angioplasty, and stent placement.
Table II. Life table data for 25 arteries treated with percutaneous intentional extraluminal recanalization
Interval
(mo)
No. of grafts at
risk at start
No. of
failed grafts
No. withdrawn patent
Interval patency
rate (%)
Cumulative
patency rate (%)
Standard
error (%)Duration Death
0-1 25 2 0 0 0.92 1.0 0
1-2 23 0 0 0 1.0 0.92 5.4
3-5 23 0 0 1 1.0 0.92 5.4
6-8 22 0 3 2 1.0 0.92 5.5
9-11 17 0 3 0 1.0 0.92 6.3
12-14 14 0 1 2 1.0 0.92 6.9
15-17 11 1 4 1 0.88 0.81 10.6
18-20 5 0 1 1 1.0 0.81 15.8
21-23 3 0 1 0 1.0 0.81 20.3
24-26 2 0 0 0 1.0 0.81 24.9
27-29 2 1 0 0 0.50 0.41 22.2
30-32 1 0 0 1 1.0 0.41 31.5
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sion of previously patent tibial arteries. In our study, no
procedure resulted in significant arterial perforation, which
confirms our clinical impression that the risk for perforation
is low. Although no patient in our series was a candidate for
arterial bypass grafting, the European studies found that
initial or subsequent failure of PIER did not affect ability to
perform subsequent arterial bypass surgery.1
Our primary patency rate of 92% at 1 year is higher than
that reported from European centers. The most successful
result previously published was reported by Bolia et al,8,9
who found a 71% patency rate at 12 months. Other reports
have been less favorable. Reekers et al1 reported a 59%
primary patency rate at the same interval, similar to the 53%
patency rate at 1 year noted by Nydahl et al4 and the 56%
primary and secondary patency rates at 1 year noted by
Vraux et al.7 McCarthy et al,5 reviewing 69 procedures
from the United Kingdom, noted a 74% technical success
rate and a discouraging 51% primary patency rate at 6
months.
In most reports and in our own experience, early or late
failure precludes follow-up endovascular intervention.1 In-
asmuch as failure results from thrombosis of the dissection
channel rather than progressive myointimal hyperplasia or
atherosclerosis, no opportunity is afforded for dilation of a
stenotic segment, patch angioplasty, or even segmental
resection or bypass grafting. No secondary procedures per-
formed after failed PIER were successful in our study
patients, and our secondary patency rate, like that of others,
matches our primary patency and clinical success rate.
The use of adjuvant medication is important to techni-
cal success and continued patency of the recanalized seg-
ment. All of our patients were given aspirin, usually 325
mg, before the procedure and during follow-up, received
systemic and local heparin during the procedure, and were
given maintenance integulin during the critical initial 24
hours after the procedure. Although we cannot make rec-
ommendations on the basis of our data, warfarin sodium or
enoxaperin may be useful for long-term success.
Our patients underwent duplex US scanning of the
treated artery at 3-month intervals for the first 2 years, to
identify stenotic areas and to provide objective evidence of
patency. However, neither of two arteries that became
occluded during follow-up demonstrated stenosis on du-
plex US scans before occlusion, and the data confirm our
suspicion that these arteries, similar to prosthetic grafts,
occlude rapidly, without identifiable stenotic lesions that
could be repaired to prevent thrombosis. We therefore
cannot justify routine duplex US scanning surveillance to
minimize risk for thrombosis, and most European centers
have not used any objective tests to detect thrombosis,
relying on ABI to determine patency.
Other reports suggest that calcification in the wall of
the occluded artery makes recanalization difficult and pre-
disposes to technical failure. However, without objective
data regarding extent of calcification, and given our overall
technical success rate without taking into account degree of
calcification, we do not believe there are any lesion-specific
factors that represent an absolute contraindication to
PIER. Our small number of failures does not allow mean-
ingful statistical analysis.
The high mortality in this series attests to the severity of
the underlying medical illness in these patients. Only 60%
of patients were alive at mean follow-up of 13 months.
However, no patient in whom the procedure was successful
required major amputation or had rest pain. For these
patients without other viable alternatives, this approach
eliminated the need for major arterial reconstruction or
amputation. Although we do not have detailed information
regarding cost of PIER, our impression is that the overall
cost of the procedure, including arteriography suite time,
stents, ICU follow-up, and professional fees, is comparable
to that for prosthetic distal bypass surgery.
CONCLUSION
PIER is technically possible in most patients with fem-
oropopliteal occlusion. The procedure, in our experience
and that of others, is reasonably safe, with a low incidence
of complications. When successful, the procedure results in
improvement in ABI, provides effective relief from rest
pain, and enables wound healing. The procedure results in
good short-term patency of the recanalized artery, but
patency beyond 1 year cannot be reliably determined from
our data. Aspirin and possibly anticoagulation therapy are
recommended and are thought to improve technical suc-
cess and short-term patency. Routine duplex US scanning
or noninvasive tests cannot be justified clinically, but have
been useful in providing objective follow-up data. PIER is
effective in patients without autologous vein, with major
contraindications to surgery, and with limited life expect-
ancy. Further studies with longer follow-up are required
before PIER can be recommended as a potentially viable
alternative to arterial bypass grafting in selected patients.
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